{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-000610","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2026-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.421880+00:00","generated_at":"2026-05-16T06:59:16.898220+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Zeo ScientifiX appoints Dr. John Kisiday as CSO with salary $175K and 50K stock grant","bullets":["Dr. Kisiday, 55, has 30 years experience in tissue-engineering and regenerative medicine; started Jan 23, 2026.","Base salary of $175,000; eligible for performance bonus and new-opportunity royalty compensation.","Stock grant of 50,000 shares under 2021 Incentive Plan; 20K vest at 1yr anniversary, 30K at 2yr anniversary.","Severance: after 90 days, if terminated without cause or resigns for good reason, gets 1/4 month salary per 3 months completed.","Relocation reimbursement up to $10,000; initially remote from Colorado but expected to relocate to Florida headquarters."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-000610","json":"https://secwatch.observer/filing/0001829126-26-000610.json","markdown":"https://secwatch.observer/filing/0001829126-26-000610.md","text":"https://secwatch.observer/filing/0001829126-26-000610.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912626000610/0001829126-26-000610-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912626000610/zeoscientifix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:59:16.898220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}